Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26- Year-Old Women
Brief Summary: The purpose of this study was to evaluate the safety, efficacy, and immunogenicity of V503 in comparison to GARDASIL. The primary hypotheses tested in the study were 1) V503 administered to 16- to 26-year-old adolescents and young women is generally well-tolerated, 2) V503 reduces combined incidence of Human Papillomavirus (HPV) Type 31/33/45/52/58-related disease compared with GARDASIL, and 3) V503 induces non-inferior geometric mean titers for HPV Type 6/11/16/18 antibodies compared with GARDASIL.


Options:
A: Arm Label: HPV-16/18 Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV 16/18 L1 AS04 | Arm Label: HPV-TETRA A Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18/31/45 L1 AS04 Formulation 1 | Arm Label: HPV-TETRA B Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18/31/45 L1 AS04 Formulation 2 | Arm Label: HPV-TETRA C Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18/31/45 L1 AS04 Formulation 3 | Arm Label: HPV-TETRA D Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18/31/45 L1 AS04 Formulation 4 | Arm Label: HPV-TETRA E Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18/31/45 L1 AS04 Formulation 5 | Arm Label: HPV-TETRA F Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18/31/45 L1 AS04 Formulation 6 | Intervention Type: BIOLOGICAL; Name: HPV 16/18 L1 AS04; Assigned to Arm(s): HPV-16/18 Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18/31/45 L1 AS04 Formulation 1; Assigned to Arm(s): HPV-TETRA A Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18/31/45 L1 AS04 Formulation 2; Assigned to Arm(s): HPV-TETRA B Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18/31/45 L1 AS04 Formulation 3; Assigned to Arm(s): HPV-TETRA C Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18/31/45 L1 AS04 Formulation 4; Assigned to Arm(s): HPV-TETRA D Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18/31/45 L1 AS04 Formulation 5; Assigned to Arm(s): HPV-TETRA E Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18/31/45 L1 AS04 Formulation 6; Assigned to Arm(s): HPV-TETRA F Group
B: Arm Label: Cervarix/Engerix-B A Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix, Biological: Engerix-B | Arm Label: Cervarix/Engerix-B B Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix, Biological: Engerix-B | Arm Label: Engerix-B Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Engerix-B | Intervention Type: BIOLOGICAL; Name: Cervarix; Assigned to Arm(s): Cervarix/Engerix-B A Group, Cervarix/Engerix-B B Group | Intervention Type: BIOLOGICAL; Name: Engerix-B; Assigned to Arm(s): Cervarix/Engerix-B A Group, Cervarix/Engerix-B B Group, Engerix-B Group
C: Arm Label: Low-dose V503; Type: EXPERIMENTAL; Interventions: Biological: Experimental: V503 | Arm Label: Mid-dose V503; Type: EXPERIMENTAL; Interventions: Biological: Experimental: V503 | Arm Label: High-dose V503; Type: EXPERIMENTAL; Interventions: Biological: Experimental: V503 | Arm Label: Gardasil; Type: ACTIVE_COMPARATOR; Interventions: Biological: Comparator: GARDASIL, Biological: Experimental: V503 | Intervention Type: BIOLOGICAL; Name: Comparator: GARDASIL; Assigned to Arm(s): Gardasil | Intervention Type: BIOLOGICAL; Name: Experimental: V503; Assigned to Arm(s): Gardasil, High-dose V503, Low-dose V503, Mid-dose V503
D: Arm Label: 9- to 15-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 2); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 3); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Males (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 16- to 26-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Intervention Type: BIOLOGICAL; Name: V503; Assigned to Arm(s): 16- to 26-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 2), 9- to 15-Year-Old Females (Lot 3), 9- to 15-Year-Old Males (Lot 1)

Answer: C